Showing 8,981 - 9,000 results of 18,435 for search 'significant ((((a decrease) OR (((we decrease) OR (greatest decrease))))) OR (mean decrease))', query time: 0.83s Refine Results
  1. 8981

    Image 1_Ticagrelor vs. clopidogrel in dual antiplatelet therapy after coronary artery bypass surgery: a meta-analysis.tif by Liyuan Wang (795570)

    Published 2025
    “…</p>Results<p>4 randomized controlled trials and 3 observational studies (n = 2,424) were eligible for final analysis. A + T was associated with a decreased risk of all-cause mortality (OR = 0.47, 95% CI 0.31–0.70, p < 0.001, p heterogeneity = 0.80, I<sup>2</sup> = 0%) and cardiovascular mortality (OR = 0.50, 95% CI 0.31–0.82, p = 0.006, p heterogeneity = 0.71, I<sup>2</sup> = 0%), compared with A + C group. …”
  2. 8982

    Data Sheet 1_Effects of plant extracts on patients with heart failure: a network meta-analysis of randomized controlled trials.pdf by Jieyin Deng (22563188)

    Published 2025
    “…Ethnopharmacological relevance<p>Heart failure (HF) is a major global health challenge. Traditional therapies have limitations, while recent studies highlight plant extracts’ potential due to their medicinal properties and milder side effects.…”
  3. 8983

    Data Sheet 1_Safety profile and efficacy of secukinumab in the treatment of autoimmune myasthenia gravis: a single-center retrospective study.pdf by Shuangmei Zhang (1807303)

    Published 2025
    “…Background<p>Myasthenia gravis (MG) is a chronic autoimmune disease caused by autoantibodies attacking the neuromuscular junction. …”
  4. 8984

    Image 2_Ticagrelor vs. clopidogrel in dual antiplatelet therapy after coronary artery bypass surgery: a meta-analysis.tif by Liyuan Wang (795570)

    Published 2025
    “…</p>Results<p>4 randomized controlled trials and 3 observational studies (n = 2,424) were eligible for final analysis. A + T was associated with a decreased risk of all-cause mortality (OR = 0.47, 95% CI 0.31–0.70, p < 0.001, p heterogeneity = 0.80, I<sup>2</sup> = 0%) and cardiovascular mortality (OR = 0.50, 95% CI 0.31–0.82, p = 0.006, p heterogeneity = 0.71, I<sup>2</sup> = 0%), compared with A + C group. …”
  5. 8985

    DataSheet1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.pdf by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  6. 8986

    Supplementary file 1_Short-term fasting before living kidney donation has an immune-modulatory effect.pdf by Christiaan A. J. Oudmaijer (12006320)

    Published 2025
    “…STF changes the levels and phenotype of immune cells, reducing the abundance and activation of T cells, including regulatory T cells, increased presence of (naïve) B cells, and elevation of type 1 conventional DCs (cDC1s). In addition, a decrease in central memory T cells was observed.…”
  7. 8987

    Data Sheet 1_Short-term fasting before living kidney donation has an immune-modulatory effect.docx by Christiaan A. J. Oudmaijer (12006320)

    Published 2025
    “…STF changes the levels and phenotype of immune cells, reducing the abundance and activation of T cells, including regulatory T cells, increased presence of (naïve) B cells, and elevation of type 1 conventional DCs (cDC1s). In addition, a decrease in central memory T cells was observed.…”
  8. 8988

    Table1_Age and gender influence on clinical manifestations of thyroid-associated ophthalmopathy: a case series of 2479 Chinese patients.xlsx by Mei Yang (51996)

    Published 2024
    “…Background<p>Significant individual differences exist in the clinical manifestations of thyroid-associated ophthalmopathy (TAO). …”
  9. 8989

    Image 5_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

    Published 2025
    “…Background<p>We used an algorithm to determine age- and sex-specific reference intervals (RIs) for copper, zinc, calcium, magnesium, iron, and lead in blood. …”
  10. 8990

    Image 3_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

    Published 2025
    “…Background<p>We used an algorithm to determine age- and sex-specific reference intervals (RIs) for copper, zinc, calcium, magnesium, iron, and lead in blood. …”
  11. 8991

    Image 2_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

    Published 2025
    “…Background<p>We used an algorithm to determine age- and sex-specific reference intervals (RIs) for copper, zinc, calcium, magnesium, iron, and lead in blood. …”
  12. 8992

    Image 4_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

    Published 2025
    “…Background<p>We used an algorithm to determine age- and sex-specific reference intervals (RIs) for copper, zinc, calcium, magnesium, iron, and lead in blood. …”
  13. 8993

    Table 1_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.docx by Junqiang Li (491954)

    Published 2025
    “…Background<p>We used an algorithm to determine age- and sex-specific reference intervals (RIs) for copper, zinc, calcium, magnesium, iron, and lead in blood. …”
  14. 8994

    Image 6_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

    Published 2025
    “…Background<p>We used an algorithm to determine age- and sex-specific reference intervals (RIs) for copper, zinc, calcium, magnesium, iron, and lead in blood. …”
  15. 8995

    Inference of cell-type proportions from bulk RNAseq and dynamics during myocardial infarction in α1A-AR-KO mice. by Brian Gural (21781982)

    Published 2025
    “…<b>(E)</b> Results from a Dirichlet regression modeling cell type proportion as influenced by cmAKO, MI, and their interaction, revealing significant effects on several cardiac cell types. …”
  16. 8996

    Threading Behavior and Dynamics of Ring-Linear Polymer Blends under Poiseuille Flow by Deyin Wang (6028850)

    Published 2024
    “…We investigate the ring-linear polymer blends under Poiseuille flow across a range of flow intensities. …”
  17. 8997

    Image 2_A comprehensive study of hip dislocation: global health burden from 1990 to 2021 and its predictions to 2030.pdf by Xu Zheng (296676)

    Published 2025
    “…</p>Conclusion<p>The disease burden of hip dislocation remains a significant public health challenge. Data-driven analysis is pivotal for guiding clinical practice, shaping public health policies, and ensuring optimal allocation of healthcare resources. …”
  18. 8998

    Image 1_A comprehensive study of hip dislocation: global health burden from 1990 to 2021 and its predictions to 2030.tif by Xu Zheng (296676)

    Published 2025
    “…</p>Conclusion<p>The disease burden of hip dislocation remains a significant public health challenge. Data-driven analysis is pivotal for guiding clinical practice, shaping public health policies, and ensuring optimal allocation of healthcare resources. …”
  19. 8999

    Table 2_A comprehensive study of hip dislocation: global health burden from 1990 to 2021 and its predictions to 2030.docx by Xu Zheng (296676)

    Published 2025
    “…</p>Conclusion<p>The disease burden of hip dislocation remains a significant public health challenge. Data-driven analysis is pivotal for guiding clinical practice, shaping public health policies, and ensuring optimal allocation of healthcare resources. …”
  20. 9000

    Table 1_A comprehensive study of hip dislocation: global health burden from 1990 to 2021 and its predictions to 2030.docx by Xu Zheng (296676)

    Published 2025
    “…</p>Conclusion<p>The disease burden of hip dislocation remains a significant public health challenge. Data-driven analysis is pivotal for guiding clinical practice, shaping public health policies, and ensuring optimal allocation of healthcare resources. …”